Oman External Counterpulsation Devices Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Oman External Counterpulsation Devices Market Overview

• The Oman External Counterpulsation Devices Market is valued at approximately USD 16–17 million, based on a five-year historical analysis and triangulation from global and regional external counterpulsation and cardiovascular device markets. This growth is primarily driven by the increasing prevalence of cardiovascular diseases in Oman and the rising awareness of non-invasive treatment options among healthcare providers and patients. The demand for external counterpulsation devices has increased as they offer a viable alternative to surgical interventions for refractory angina and heart failure, enhancing patient outcomes, supporting symptom relief, and reducing recovery times.
• Key players in this market are concentrated in major cities such as Muscat and Salalah, where advanced healthcare facilities and specialized cardiac centers are located. The dominance of these cities is attributed to their robust healthcare infrastructure, higher concentration of tertiary hospitals, availability of skilled cardiologists and technicians, and a growing urban population with increasing healthcare needs, particularly in cardiovascular care.
• In 2023, the Omani government implemented regulations to promote the use of advanced medical technologies, including external counterpulsation devices. Under the Medical Devices Regulation issued by the Ministry of Health pursuant to Royal Decree No. 33/2013 (Law on the Practice of the Medical Profession and Allied Health Professions), all medical devices must be registered with the Directorate General of Pharmaceutical Affairs and Drug Control, comply with quality and safety standards aligned with Gulf and international norms, and be imported and used only by licensed healthcare facilities. This framework supports the adoption of innovative non-invasive cardiovascular treatment technologies and improves patient access through controlled procurement and standardized clinical use.

Oman External Counterpulsation Devices Market Segmentation

By Product:The product segmentation includes various types of devices and accessories that cater to the needs of healthcare providers and patients. The subsegments are EECP Systems / ECP Devices, Accessories & Consumables (Cuffs, Hoses, Sensors), Software & Monitoring Modules, and Others. Among these, EECP Systems / ECP Devices dominate the market, in line with global trends where device hardware accounts for the largest revenue share due to its central role in therapy delivery and higher unit prices. Their effectiveness in treating cardiovascular conditions such as refractory angina and heart failure, growing clinical evidence base, and increasing acceptance in hospital and specialized clinic settings support this dominance.

By Mobility:The mobility segmentation categorizes devices based on their operational design, including Fixed / Stationary Systems, Portable / Mobile Systems, Home-use / Ambulatory Systems, and Others. Fixed / Stationary Systems are the leading subsegment, consistent with international market patterns in which most ECP therapies are delivered in hospitals and dedicated cardiac centers using full-sized console systems that support continuous, protocol-based treatment for patients with chronic cardiovascular conditions. Their widespread use in institutional settings is driven by reimbursement alignment, the need for supervised therapy, and integration with other diagnostic and monitoring equipment.

Oman External Counterpulsation Devices Market Competitive Landscape

The Oman External Counterpulsation Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Vaso Corporation, CardioMedics, Inc., ScottCare Cardiovascular Solutions, Renew Group Private Limited, ACS Diagnostics, Inc., Vamed Medical Instrument Co., Ltd., Shanghai Goodmed Medical Device Co., Ltd., ANAND MEDITECH, Medtronic plc, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Terumo Corporation contribute to innovation, geographic expansion, and service delivery in this space.

Oman External Counterpulsation Devices Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Cardiovascular Diseases:The World Health Organization reported that cardiovascular diseases (CVDs) account for approximately 38% of all deaths in Oman, with over 5,500 fatalities annually. This alarming statistic underscores the urgent need for effective treatment options, including external counterpulsation devices. As the population ages, the number of individuals suffering from CVDs is projected to rise, driving demand for innovative therapies that can improve patient outcomes and reduce mortality rates associated with heart conditions.
• Rising Awareness About Non-Invasive Treatment Options:In recent years, there has been a significant increase in public and professional awareness regarding non-invasive treatment methods for cardiovascular diseases. Educational campaigns and health seminars have reached over 65% of the population, highlighting the benefits of counterpulsation therapy. This growing awareness is crucial as it encourages patients to seek out these advanced treatment options, thereby expanding the market for external counterpulsation devices in Oman and improving overall health outcomes.
• Technological Advancements in Counterpulsation Devices:The external counterpulsation device market is witnessing rapid technological advancements, with innovations enhancing device efficacy and patient comfort. For instance, the introduction of devices with improved algorithms and user-friendly interfaces has led to a 35% increase in patient compliance. These advancements not only improve treatment outcomes but also attract healthcare providers to adopt these technologies, further propelling market growth in Oman as hospitals seek to offer the latest in cardiovascular care.

Market Challenges

• High Initial Costs of Devices:One of the significant barriers to the adoption of external counterpulsation devices in Oman is their high initial cost, which can exceed OMR 30,000 per unit. This financial burden limits accessibility for many healthcare facilities, particularly smaller clinics and hospitals. As a result, the high upfront investment required for these devices can deter healthcare providers from incorporating them into their treatment offerings, ultimately hindering market growth.
• Limited Awareness Among Healthcare Professionals:Despite the rising awareness among patients, many healthcare professionals in Oman remain unaware of the benefits and applications of external counterpulsation therapy. A survey indicated that only 45% of cardiologists are familiar with these devices. This knowledge gap can lead to underutilization of effective treatment options, limiting patient access to innovative therapies and stalling market expansion in the region.

Oman External Counterpulsation Devices Market Future Outlook

The future of the external counterpulsation devices market in Oman appears promising, driven by increasing healthcare investments and a growing focus on innovative treatment solutions. As the government prioritizes healthcare infrastructure development, the integration of advanced medical technologies is expected to enhance patient care. Additionally, the rising trend of personalized medicine will likely lead to tailored treatment plans, further boosting the adoption of counterpulsation devices and improving patient outcomes in future.

Market Opportunities

• Expansion of Healthcare Infrastructure:The Omani government is investing over OMR 1.5 billion in healthcare infrastructure, creating opportunities for the introduction of advanced medical devices. This expansion will facilitate the integration of external counterpulsation devices into hospitals and clinics, enhancing treatment options for cardiovascular patients and driving market growth.
• Increasing Government Support for Healthcare Innovation:With the government’s commitment to healthcare innovation, including grants and incentives for research, the market for external counterpulsation devices is poised for growth. This support encourages local manufacturers to develop and market these devices, potentially reducing costs and increasing accessibility for healthcare providers across Oman.